Grifols is a global company that since 1909 has enhanced the health and well-being of people around the world. Our four divisions - Bioscience, Diagnostic, Hospital and Bio Supplies - develop, produce and market innovative solutions and services in more than 100 countries.
Commitment to Society
Our mission is to improve the health and well-being of patients around the world. Since 1909, we have advanced science, inspired innovation and supported the scientific community and its research efforts worldwide.
Commitment to Donors & Patients
Thanks to our donors' generosity we develop essential plasma medicines to treat chronic, rare and, at times, life-threatening conditions. We also provide diagnostic solutions, instruments and services for hospitals and pharmacies.
We trace our roots back to 1909 when Dr. Josep Antoni Grifols i Roig founded the laboratory Instituto Central de Análisis Clínicos, Bacteriológicos y Químicos in Barcelona.
The Grifols Hemophilia Awareness Global Awards (GHAGA)
A periodic award focused on encouraging healthcare providers, hemophilia treatment centers as well as hemophilia societies to submit proposals that would contribute to improving the care of hemophilia patients and enhancing their quality of life.
January 18, 2021
Grifols begins clinical trial of a new treatment that would provide immediate immunity against COVID-19
December 16, 2020
Grifols creates a Sustainability Committee to strengthen its long-term sustainable growth model
Our business is organized into four divisions: Bioscience, Diagnostic, Hospital and Bio Supplies.
We are committed to a long-term vision that creates a sustainable, positive impact on the communities in which we operate.
Since Grifols was founded, our ongoing innovation has helped shape industry standards in the plasma industry.
This information is aimed exclusively at authorized healthcare professionals to prescribe or supply medicinal products and its correct interpretation requires specialized training.
Are you a healthcare professional?